Skip to main content
. 2022 Dec 15;12(12):5500–5515.

Table 1.

Clinical characteristics of patients with CRC in different cohorts

Cohort I (n = 84) Cohort II (n = 14) Cohort III (n = 5)
Gender
    Male 45 (53.6%) 7 (50.0%) 2 (40.0%)
    Female 39 (46.4%) 7 (50.0%) 3 (60.0%)
Median age (range)
    <65 63 (75.0%) 6 (42.9%) 1 (20.0%)
    ≥65 21 (25.0%) 8 (57.1%) 4 (80.0%)
T stage
    T1 5 (6.0%) 0 (0.0%) 0 (0.0%)
    T2 16 (19.0%) 0 (0.0%) 0 (0.0%)
    T3 49 (58.3%) 9 (64.3%) 2 (40.0%)
    T4 14 (16.7%) 5 (35.7%) 3 (60.0%)
N stage
    N0 58 (69.0%) 8 (57.1%) 2 (40.0%)
    N+ 26 (31.0%) 6 (42.9%) 3 (60.0%)
M stage
    M0 70 (83.3%) 12 (85.7%) 5 (100.0%)
    M1 14 (16.7%) 2 (14.3%) 0 (0.0%)
Stage
    I 17 (20.2%) 0 (0.0%) 0 (0.0%)
    II 35 (41.7%) 7 (50.0%) 2 (40.0%)
    III 18 (21.4%) 5 (35.7%) 3 (60.0%)
    IV 14 (16.7%) 2 (14.3%) 0 (0.0%)
Location
    Colon 36 (42.9%) 9 (64.3%) 5 (100.0%)
    Colon/Rectum 48 (57.1%) 5 (35.7%) 0 (0.0%)

Cohort 3 ⊆ Cohort 2 ⊆ Cohort 1.